⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for nose cancer

Every month we try and update this database with for nose cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Tabelecleucel in Combination With Pembrolizumab in Subjects With Epstein-Barr Virus-associated Nasopharyngeal Carcinoma (EBV+ NPC)NCT03769467
Nasopharyngeal ...
Nasopharyngeal ...
Epstein-Barr Vi...
Epstein-Barr Vi...
Epstein-Barr Vi...
tabelecleucel
pembrolizumab
12 Years - Atara Biotherapeutics
A Clinical Study on Oncolytic Virus Injection (R130 OV) for the Treatment of Relapsed/Refractory Head and Neck CancerNCT05830240
Head and Neck C...
Esophageal Canc...
Otorhinolaryngo...
Ear Cancer
Nose Cancer
Laryngeal Cance...
Pharyngeal Canc...
Recombinant onc...
18 Years - 75 YearsShanghai Yunying Medical Technology
A Phase III Trial Evaluating Chemotherapy and Immunotherapy for Advanced Nasopharyngeal Carcinoma (NPC) PatientsNCT02578641
Nasopharyngeal ...
autologous EBV ...
combination IV ...
18 Years - Tessa Therapeutics
Tabelecleucel in Combination With Pembrolizumab in Subjects With Epstein-Barr Virus-associated Nasopharyngeal Carcinoma (EBV+ NPC)NCT03769467
Nasopharyngeal ...
Nasopharyngeal ...
Epstein-Barr Vi...
Epstein-Barr Vi...
Epstein-Barr Vi...
tabelecleucel
pembrolizumab
12 Years - Atara Biotherapeutics
A Clinical Study on Oncolytic Virus Injection (R130 OV) for the Treatment of Relapsed/Refractory Head and Neck CancerNCT05830240
Head and Neck C...
Esophageal Canc...
Otorhinolaryngo...
Ear Cancer
Nose Cancer
Laryngeal Cance...
Pharyngeal Canc...
Recombinant onc...
18 Years - 75 YearsShanghai Yunying Medical Technology
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: